期刊文献+

中医药调控Nrf2-ARE信号通路治疗慢性肾脏病的研究进展 被引量:2

Research Progress of Traditional Chinese Medicine Regulating Nrf2-ARE Signaling Pathway in the Treatment of Renal Diseases
在线阅读 下载PDF
导出
摘要 越来越多研究证实氧化应激在慢性肾脏病的进展中扮演着不可或缺的角色。Nrf2-ARE信号通路是机体抗氧化应激反应的重要应答机制之一,其激活后能启动下游多种保护性基因的转录以增强细胞抗氧化、清除毒物的防御保护作用,已经成为当今肾脏病治疗的重要靶点之一。该文从Nrf2-ARE信号通路的调控机制角度出发,阐述近年来中医药在干预治疗慢性肾脏病中的研究成果和进展,为各种中药单体、中药复方在未来临床中治疗慢性肾脏病提供更多新的思考和方向。 More and more studies have confirmed that oxidative stress plays an indispensable role in the development of chronic kidney disease.Nrf2-ARE signaling pathway is one of the important response mechanisms of the body′s antioxidant stress response.After activation,Nrf2-ARE can activate transcription of a variety of downstream protective genes to enhance the defense and protection effect of cellular antioxidant and toxin clearance,which has become one of the important targets in the treatment of renal diseases.From the perspective of the regulatory mechanism of Nrf2-ARE signaling pathway,this paper expounds the research achievements and progress of traditional Chinese medicine in the intervention treatment of chronic kidney disease in recent years,so as to provide more new thoughts and directions for the future clinical treatment of chronic kidney disease by various traditional Chinese medicine monomers and traditional Chinese medicine compounds.
作者 官莹洁 赵爱萍 GUAN Ying-jie;ZHAO Ai-ping(Fujian University of Traditional Chinese Medicine,Fuzhou 350122,China;People′s Hospital affiliated to Fujian University of Traditional Chinese Medicine,Fuzhou 350004,China)
出处 《海峡药学》 2021年第6期91-94,共4页 Strait Pharmaceutical Journal
基金 国家中医临床研究基地专项课题(JDZX201934) 阮诗玮福建省名老中医药专家传承工作室项目(闽卫办中2018:216)。
关键词 Nrf2-ARE 中医药 糖尿病肾病 狼疮性肾炎 慢性肾脏病 Nrf2-ARE Traditional Chinese medicine Diabetic nephropathy Lupus nephritis Chronic kidney disease
  • 相关文献

参考文献15

二级参考文献130

  • 1冯长根,张琳霞,刘霞.中草药来源的醛糖还原酶抑制剂的研究进展[J].中国中药杂志,2005,30(19):1496-1500. 被引量:25
  • 2何立群.慢性肾衰竭的诊断、辨证分型及疗效评定(试行方案)[J].上海中医药杂志,2006,40(8):8-9. 被引量:533
  • 3马航,朱杰,张建辉,吴红萍.微炎性反应状态在慢性肾功能衰竭患者心血管病变中的作用[J].疑难病杂志,2007,6(7):392-394. 被引量:5
  • 4Arnold P, Mojumder D, Detoledo J, et al. Pathophys- iological processes in multiple sclerosis: focus on nu- clear factor erythroid-2-related factor 2 and emerging pathways [ J]. Clin Pharmacol, 2014, 6: 35-642.
  • 5Kansanen E, Kuosmanen SM, Leinonen H, et al. The Keapl-Nrt2 pathway: Mechanisms of activation and dysregulation in cancer [ J]. Redox Biol, 2013, 1 (1) : 45-49.
  • 6Kumar H, Kim IS, More SV, et al. Natural product- derived pharmacological modulators of Nrf2/ARE path- way for chronic diseases [J]. Nat Prod Rep, 2014, 31(1) : 109-139.
  • 7Moi P, Chan K, Asunis I, et al. Isolation of NF-E2- related factor 2 ( Nrf2 ), a NF-E2-1ike basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control re- gion [J]. Proc Natl Acad Sci U S A, 1994, 91(21) : 9926-9930.
  • 8Wang H, Liu K, Geng M, et al. RXRalpha inhibits the NRF2-ARE signaling pathway through a direct in- teraction with the Neh7 domain of NRF2 [ J ]. Cancer Res, 2013, 73(10): 3097-3108.
  • 9Takagi Y, Kobayashi M, Li L, et al. MatT, a new member of the small Maf protein family in zebrafish [ J]. Biochem Biophys Res Commun, 2004, 320( 1 ) : 62-69.
  • 10Magesh S, Chen Y, Hu L. Small molecule modulators of Keapl-Nrt2-ARE pathway as potential preventive and therapeutic agents [J]. Med Res Rev, 2012, 32 (4) : 687-726.

共引文献184

同被引文献17

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部